Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
22 hedge funds and large institutions have $14.9M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
43% more capital invested
Capital invested by funds: $10.4M → $14.9M (+$4.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 23 → 22 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$12.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$86 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$492K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.79K |
| 3 |
NC
Noked Capital
Tel Aviv,
Israel
|
-$4K |
| 4 |
NI
Noked Israel
Ramat Hasharon,
Israel
|
-$4K |
| 5 |
LCG
Luxor Capital Group
New York
|
-$11 |
CTV.WS Hedge Fund Activity: Q3 2022 in Review
22 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q3 2022, worth a combined $14.9M — up 43% from $10.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CTV.WS and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $12.2K. The largest seller was BAMCO Inc, cutting an estimated $492K.
- 22 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q3 2022, down from 23 in Q2 2022.
- Funds reported $14.9M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2022, up 43% quarter-over-quarter.
- 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2022 was Saba Capital Management, an estimated $12.2K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2022 was BAMCO Inc, an estimated $492K sold.
Based on aggregated 13F filings for Q3 2022.